Crowdonomics
All companies

Dimicron Inc.

Operating

Healthcare · Orem, UT

Estimated pre-money ⓘ
$30.4M
As of Sep 2022 · from Reg A Offering (2022) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$243,739
Across 1 round since 2022
Latest share price
$6.07
Reg A+ · Equity · Sep 2022 offering price

Financials

FY2021–FY2023 · from SEC filings · hover any figure for its source
$512K
−$8.1M
2021
$207K
−$8.3M
2022
$390K
−$9.1M
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021 audited
FY2022 audited
FY2023 audited
Income statement
Revenue
$512,149
$206,922
$390,455
Cost of goods sold
$49,831
-$70,366
-$182,891
Gross margin
90%
66%
53%
Net income
-$8,079,571
-$8,330,086
-$9,084,988
Balance sheet
Cash
$1,442,744
$220,048
$961,785
Accounts receivable
$147,372
$105,922
$189,409
Total assets
$2,924,697
$1,623,112
$2,402,726
Long-term debt
$45,730,124
—
—
Total liabilities
$65,069,897
$71,479,564
$80,461,151
Other
Headcount
16
—
—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$30.4M
est. pre-money
Reg A+ · Equity · Sep 2022

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Jan 13, 2023
Series B Preferred Stock · 10.1%Common Stock · 89.9%
ClassOutstandingVotes / shareShare of totalVotesLast price
Series B Preferred Stockpreferred506,874—10.1%100.0%—
Common Stock4,505,393none89.9%0%$6.07Sep 2022
Total5,012,267100%100%

Principal holders% as the filing states it, Apr 29, 2024

  • Brigham Young University A-84,602 Preferred18.8%of company
  • Trust of Estate of Wayne Tew1,862,997 Common Stock9.9%of company
  • Orem84,058 Preferred7.94%of company
  • Duane L. Madsen Trust32,168 Common Stock1.52%of company

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Reg A+ · Equity · Sep 2022Closedvia DealMaker
Raised $243.7K / $15.8MEst. pre-money $30.4M

Team

13 people
Alan S. Layton
Chief Executive Officer
Edward Dennis Bird, Jr.
Chief Strategy Officer, EVP Corporate Development
Jeff Alan Bennett
President, Chief Operating Officer
Eric Lange
VP, Research & Development
Curt Ence
Comptroller
David Harding, PhD.
Principal Engineer
Steven Ulmer
Manufacturing Manager
Armen Khachatryan, MD
Director
Duane Madsen
Director
Show 4 more people
Jeff K. Taylor, MD
Director
Suzanne Winters, PhD.
Director
Tim Stratford
Director
Whitney Clayton
Director

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

SEC filings

  • Form 1-KApr 29, 20240001683168-24-002796
    EDGAR
  • Form 1-ZApr 29, 20240001683168-24-002798
    EDGAR
  • Form 1-SASep 26, 20230001683168-23-006705
    EDGAR
  • Form 1-KMay 18, 20230001683168-23-003503
    EDGAR
  • Form 253G2Jan 25, 20230001683168-23-000305
    EDGAR
  • Form QUALIFJan 24, 20239999999994-23-000039
    EDGAR
  • Form 1-A/AJan 13, 20230001683168-23-000181
    EDGAR
  • Form 1-ASep 22, 20220001683168-22-006529
    EDGAR
Source: SEC EDGARCIK 0001944139UTShare price $6.07Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.